SPP1 and metabolic syndrome: For instance, research has shown that elevated blood glucose levels increase SPP1 secretion, which can contribute to insulin resistance by promoting chronic low-grade inflammation and interfering with insulin signaling pathways like PI3K/Akt, which plays a key role in MetS progression, especially diabetes.